Exploring the multidimensional nature of repetitive and restricted behaviors and interests (RRBI) in autism: neuroanatomical correlates and clinical implications.
Cortico-striatal-thalamo-cortical loop
Phenotype
RRB
Journal
Molecular autism
ISSN: 2040-2392
Titre abrégé: Mol Autism
Pays: England
ID NLM: 101534222
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
10
04
2023
accepted:
06
11
2023
medline:
29
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
epublish
Résumé
Repetitive and restricted behaviors and interests (RRBI) are core symptoms of autism with a complex entity and are commonly categorized into 'motor-driven' and 'cognitively driven'. RRBI symptomatology depends on the individual's clinical environment limiting the understanding of RRBI physiology, particularly their associated neuroanatomical structures. The complex RRBI heterogeneity needs to explore the whole RRBI spectrum by integrating the clinical context [autistic individuals, their relatives and typical developing (TD) individuals]. We hypothesized that different RRBI dimensions would emerge by exploring the whole spectrum of RRBI and that these dimensions are associated with neuroanatomical signatures-involving cortical and subcortical areas. A sample of 792 individuals composed of 267 autistic subjects, their 370 first-degree relatives and 155 TD individuals was enrolled in the study. We assessed the whole patterns of RRBI in each individual by using the Repetitive Behavior Scale-Revised and the Yale-Brown Obsessive Compulsive Scale. We estimated brain volumes using MRI scanner for a subsample of the subjects (n = 152, 42 ASD, 89 relatives and 13 TD). We first investigated the dimensionality of RRBI by performing a principal component analysis on all items of these scales and included all the sampling population. We then explored the relationship between RRBI-derived factors with brain volumes using linear regression models. We identified 3 main factors (with 30.3% of the RRBI cumulative variance): Factor 1 (FA1, 12.7%) reflected mainly the 'motor-driven' RRBI symptoms; Factor 2 and 3 (respectively, 8.8% and 7.9%) gathered mainly Y-BOCS related items and represented the 'cognitively driven' RRBI symptoms. These three factors were significantly associated with the right/left putamen volumes but with opposite effects: FA1 was negatively associated with an increased volume of the right/left putamen conversely to FA2 and FA3 (all uncorrected p < 0.05). FA1 was negatively associated with the left amygdala (uncorrected p < 0.05), and FA2 was positively associated with the left parietal structure (uncorrected p = 0.001). Our results suggested 3 coherent RRBI dimensions involving the putamen commonly and other structures according to the RRBI dimension. The exploration of the putamen's integrative role in RSBI needs to be strengthened in further studies.
Sections du résumé
BACKGROUND
BACKGROUND
Repetitive and restricted behaviors and interests (RRBI) are core symptoms of autism with a complex entity and are commonly categorized into 'motor-driven' and 'cognitively driven'. RRBI symptomatology depends on the individual's clinical environment limiting the understanding of RRBI physiology, particularly their associated neuroanatomical structures. The complex RRBI heterogeneity needs to explore the whole RRBI spectrum by integrating the clinical context [autistic individuals, their relatives and typical developing (TD) individuals]. We hypothesized that different RRBI dimensions would emerge by exploring the whole spectrum of RRBI and that these dimensions are associated with neuroanatomical signatures-involving cortical and subcortical areas.
METHOD
METHODS
A sample of 792 individuals composed of 267 autistic subjects, their 370 first-degree relatives and 155 TD individuals was enrolled in the study. We assessed the whole patterns of RRBI in each individual by using the Repetitive Behavior Scale-Revised and the Yale-Brown Obsessive Compulsive Scale. We estimated brain volumes using MRI scanner for a subsample of the subjects (n = 152, 42 ASD, 89 relatives and 13 TD). We first investigated the dimensionality of RRBI by performing a principal component analysis on all items of these scales and included all the sampling population. We then explored the relationship between RRBI-derived factors with brain volumes using linear regression models.
RESULTS
RESULTS
We identified 3 main factors (with 30.3% of the RRBI cumulative variance): Factor 1 (FA1, 12.7%) reflected mainly the 'motor-driven' RRBI symptoms; Factor 2 and 3 (respectively, 8.8% and 7.9%) gathered mainly Y-BOCS related items and represented the 'cognitively driven' RRBI symptoms. These three factors were significantly associated with the right/left putamen volumes but with opposite effects: FA1 was negatively associated with an increased volume of the right/left putamen conversely to FA2 and FA3 (all uncorrected p < 0.05). FA1 was negatively associated with the left amygdala (uncorrected p < 0.05), and FA2 was positively associated with the left parietal structure (uncorrected p = 0.001).
CONCLUSION
CONCLUSIONS
Our results suggested 3 coherent RRBI dimensions involving the putamen commonly and other structures according to the RRBI dimension. The exploration of the putamen's integrative role in RSBI needs to be strengthened in further studies.
Identifiants
pubmed: 38012709
doi: 10.1186/s13229-023-00576-z
pii: 10.1186/s13229-023-00576-z
pmc: PMC10680239
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
45Subventions
Organisme : Investissements d'Avenir program
ID : ANR-11-IDEX-0004-02, ANR-10-COHO-10-01, ANR-12-SAMA-0014
Organisme : Investissements d'Avenir program
ID : ANR-11-IDEX-0004-02, ANR-10-COHO-10-01, ANR-12-SAMA-0014
Organisme : Investissements d'Avenir program
ID : ANR-11-IDEX-0004-02, ANR-10-COHO-10-01, ANR-12-SAMA-0014
Informations de copyright
© 2023. The Author(s).
Références
Biol Psychiatry. 1999 Feb 15;45(4):482-8
pubmed: 10071722
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Autism Res. 2017 Apr;10(4):680-689
pubmed: 27809408
Hum Brain Mapp. 2012 Jun;33(6):1470-89
pubmed: 21692142
Psychiatry Res. 2022 May;311:114498
pubmed: 35290885
Am J Psychiatry. 2018 Apr 1;175(4):359-369
pubmed: 29145754
Nat Methods. 2021 Jul;18(7):698-700
pubmed: 34194050
J Autism Dev Disord. 2015 Jan;45(1):192-202
pubmed: 25149176
Depress Anxiety. 2018 Aug;35(8):761-774
pubmed: 29920848
CNS Spectr. 2021 Feb 01;:1-7
pubmed: 33517936
Psychiatry Res. 2003 Jan 25;117(1):11-6
pubmed: 12581816
Autism Res. 2021 Nov;14(11):2373-2382
pubmed: 34278736
Am J Psychiatry. 2016 Sep 9;174(1):60-69
pubmed: 27609241
Neuropsychopharmacology. 2022 Jan;47(2):454-464
pubmed: 34725486
J Am Acad Child Adolesc Psychiatry. 2014 Sep;53(9):1001-9
pubmed: 25151423
Res Autism Spectr Disord. 2009 Oct;3(4):959-966
pubmed: 21475640
Autism Res. 2017 May;10(5):703-710
pubmed: 28266796
Neuroscience. 2017 Mar 14;345:243-255
pubmed: 27491478
Behav Brain Res. 2016 Oct 15;313:17-22
pubmed: 27388149
Front Mol Neurosci. 2023 Mar 16;16:1139118
pubmed: 37008785
Nat Commun. 2019 Oct 31;10(1):4958
pubmed: 31673008
Epidemiol Psychiatr Sci. 2013 Sep;22(3):217-21
pubmed: 23531487
Transl Psychiatry. 2022 Feb 21;12(1):70
pubmed: 35190533
Neuropsychopharmacology. 2016 Oct;41(11):2627-37
pubmed: 27125303
Front Psychol. 2022 Oct 31;13:986876
pubmed: 36389482
Hum Brain Mapp. 2007 Sep;28(9):892-903
pubmed: 17295313
Front Psychiatry. 2021 Jun 08;12:674568
pubmed: 34168582
Psychiatry Res Neuroimaging. 2020 Jan 30;295:111006
pubmed: 31760338
Mol Autism. 2015 Sep 04;6:50
pubmed: 26347127
Psychol Med. 2020 Jun;50(8):1257-1266
pubmed: 32476632
Hum Brain Mapp. 2022 Jan;43(1):23-36
pubmed: 32154629
J Am Acad Child Adolesc Psychiatry. 2014 Mar;53(3):329-40.e1-3
pubmed: 24565360
Arch Gen Psychiatry. 1994 Nov;51(11):849-59; discussion 863-4
pubmed: 7944874
Eur J Neurosci. 2022 Sep;56(5):4619-4641
pubmed: 35799402
J Psychiatry Neurosci. 2017 Nov;42(6):395-403
pubmed: 28832321
J Am Acad Child Adolesc Psychiatry. 2017 Jan;56(1):51-58
pubmed: 27993229
J Am Acad Child Adolesc Psychiatry. 2000 Oct;39(10):1208
pubmed: 11026169
Am J Med Genet A. 2015 Dec;167A(12):3019-30
pubmed: 26334118
Am J Psychiatry. 2018 May 1;175(5):453-462
pubmed: 29377733
Psychol Med. 2021 Nov;51(15):2571-2580
pubmed: 32349803
Transl Psychiatry. 2018 Apr 27;8(1):94
pubmed: 29700290
Trends Neurosci. 2015 Sep;38(9):571-8
pubmed: 26343956
Eur Psychiatry. 2007 Jan;22(1):32-8
pubmed: 17127035
Br J Psychiatry. 2017 Jan;210(1):67-74
pubmed: 27198485
Biol Psychiatry. 2020 Jun 15;87(12):1022-1034
pubmed: 31178097
Autism Res. 2015 Feb;8(1):38-51
pubmed: 25258047
Front Cell Neurosci. 2021 Jan 14;14:592710
pubmed: 33519379
Child Psychiatry Hum Dev. 2017 Dec;48(6):944-959
pubmed: 28281020
Brain Struct Funct. 2019 Mar;224(2):795-810
pubmed: 30511334
Am J Psychiatry. 2008 Oct;165(10):1299-307
pubmed: 18413702
Pediatr Neurol. 2016 Dec;65:59-63
pubmed: 27751663
Neuroimage. 2016 Apr 1;129:1-14
pubmed: 26824403
Am J Psychiatry. 1995 May;152(5):772-7
pubmed: 7726318
Autism Res. 2021 Jun;14(6):1163-1185
pubmed: 33410263
J Autism Dev Disord. 2007 Feb;37(2):251-9
pubmed: 16865546
Brain Struct Funct. 2013 Jul;218(4):929-42
pubmed: 22777602
Neuropsychobiology. 2003;47(4):171-7
pubmed: 12824738
J Autism Dev Disord. 2007 May;37(5):855-66
pubmed: 17048092
Autism Res. 2022 May;15(5):778-790
pubmed: 35238171
Front Psychiatry. 2023 Feb 14;14:958015
pubmed: 36865079
Brain Behav. 2021 Feb;11(2):e01975
pubmed: 33270358
Autism. 2015 Jan;19(1):38-52
pubmed: 24259748
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jan;4(1):50-61
pubmed: 30446435
Autism Res. 2019 Feb;12(2):274-283
pubmed: 30561911
Biol Psychiatry. 2014 Sep 1;76(5):405-11
pubmed: 24090791
Am J Psychiatry. 2017 Apr 1;174(4):387-396
pubmed: 27809572